RE:covid stock If you can work, work and save. Let your share count do its work. In regards to the other covid stocks, only two have received “better news” due US funding and joining Operations Warp Speed. Both of them are above the $80 USD mark and in terms of testing are behind ifenprodil by a complete stage. Obviously we’re comparing a vaccine stock to a treatment, but in terms of news and progress, AGNPF is only so cheap right now because their PR isn’t labeled for US release. It can’t run in the US, so must of the trading platforms can’t touch their PR. They can report on the gains, and until Thursday/Friday there wasn’t anything to write about. Now there is.
I know a lot of people like to talk about $1-$4 mark on AGNPF, but if you’ve followed the other covid stocks, their weekly gains of 1000% based off less news (much less) than what AGNPF has already accomplished, it’s easy to believe this stock pushing $10-$20 with positive testing results IN a US press release.